APIs and Excipients

Sartorius Stedim Biotech and Penn State University Announce Biotechnology Partnership

April 16, 2018

Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology.

Platform Offers Online API Trading

April 16, 2018

Kemiex trading network is designed to increase safety in the sourcing of APIs and additives.

Sanofi to Invest Roughly $430 Million in Canadian Vaccine Facility

April 12, 2018

The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.

Amgen to Build Next-Generation Biomanufacturing Plant

April 11, 2018

The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.

Lonza Opens Dedicated Cell and Gene Therapy Manufacturing Facility

April 10, 2018

The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.

Roche Acquires Regenerative Medicines Program

April 09, 2018

Roche has acquired a program to develop regenerative therapies for multiple sclerosis.

Lilly, Sigilon Partner on Encapsulated Cell Therapies for Diabetes

April 09, 2018

Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.

FDA Issues CRLs to Celltrion for Two Biosimilars

April 09, 2018

Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.

Boehringer Ingelheim and OSE in Immuno-Oncology Deal Worth $1.7 Billion

April 06, 2018

Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.

Reig Jofre and Leanbio Form Joint Venture to Develop Biosimilars

April 05, 2018

The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.